glp 1 birmingham al GLP-1 medications show little effect on cancer, study shows Practice Health - Weight Loss

More than 10 biosimilars to Humira were launched in 2023, and in October 2023, Navitus said it would favor the low-WAC (wholesale acquisition cost)/low rebate biosimilar options, including adalimumab-adaz, adalimumab-fkjp and Hadlima

J.MartinezC.NieslerB.van der VoortI.MonnikesH.StengelA.et al (2020)

ZERO SUGARS.* NO BS

Trulicity produces A1C reductions averaging 0.8% to 1.6% across its dose range

The TRIUMPH-4 Phase 3 trial in obesity with knee osteoarthritis later reported 28.7% mean weight loss at 68 weeks with retatrutide 12 mg/week, and identified a dose-related dysesthesia (nerve-tingling) signal in 8.8% of 9 mg and 20.9% of 12 mg patients (Bays et al., 2025)